TransMedics Group, Inc. is 2.3x more valuable than CONMED Corp by market capitalization ($2.58 B vs $1.11 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CNMD | TMDX |
|---|---|---|
| Market cap | $1.11 B | $2.58 B |
| US-listed rank | #2567 | #1919 |
| Revenue (latest FY) | $1.37B | $605.49M |
| Net income (latest FY) | $47.10M | $190.30M |
| Net margin | 3.4% | 31.4% |
| P/E (trailing FY) | 23.5 | 13.6 |
| SEC filings | 2,228 | 615 |
TransMedics Group, Inc. is 2.3x more valuable than CONMED Corp by market capitalization ($2.58 B vs $1.11 B).
In their latest fiscal years, CONMED Corp reported $1.37B in revenue while TransMedics Group, Inc. reported $605.49M.
Full pages: CONMED Corp and TransMedics Group, Inc., or browse the full rankings.